Stephen J. Hoffman, Chief Executive Officer at Aerpio Pharmaceuticals, Inc. (ARPO), bought 61,967 shares at $2.01 ($124K) on 2018-11-12, disclosed to the SEC on 2018-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.95 | 1,967 | $4K | 3.1% |
| 2 | $2.01 | 30,000 | $60K | 48.5% |
| 3 | $2.01 | 30,000 | $60K | 48.5% |
| Total | $2.01 avg | 61,967 | $124K | 100% |
| Filing → |
| DRNA | BUY | 2014-02-05 | $3.0M | — | Filing → |
| ACRX | BUY | 2012-05-31 | $968K | — | Filing → |
| ACRX | BUY | 2011-02-18 | $6.2M | — | Filing → |